Diseases, Conditions, Syndromes

EU approves first vaccine against common respiratory virus

The European Commission has followed the United States in approving the world's first vaccine for the Respiratory Syncytial Virus, to be used by adults aged 60 and over, its maker GlaxoSmithKline said Wednesday.

Psychology & Psychiatry

Researchers discuss results of study on vulnerable adolescents

Peer victimization and depressive symptoms, reflecting social and emotional vulnerabilities, tend to peak in early to middle adolescence. Friends play an important role in protecting adolescents from victimization and depressive ...

HIV & AIDS

Virtual village can empower vulnerable groups of people

New psychosocial stressors and widespread lifestyle changes resulted from the COVID-19 pandemic, contributing to depression, isolation, and anxiety. Many studies have explored the impact of the pandemic on the general population's ...

page 10 from 40